Back to News
Nov 3, 2025 8:00 PM

Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are plunging in extended trading Monday after the company reported third-quarter results and provided an update on its ESSENCE study.

SRPT shares are sliding on disappointing news. Find out why here.

What To Know: Sarepta reported third-quarter revenue of $399.36 million, beating analyst estimates of $338.71 million, according to Benzinga Pro. The company reported a third-quarter adjusted loss of 13 cents per share, beating estimates for a loss of 81 cents per share.

In connection with earnings, Sarepta said it completed its Phase 3 ESSENCE study ...